A record of what Ganesh Dongre said publicly, with the source. Not advice.
“Recommends buying Natco Pharma Ltd (NATCOPHARM) in the range of ₹790-800, setting a target price of ₹840 with a stop loss at ₹770. This call is for the near term, following a stock market holiday.”
Ganesh Dongre’s track record (trackable calls only): 327 graded calls · 95% CI 33–44%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.
Entry zone: ₹790–₹800. The call starts at the first close that comes into it.
Target ₹840, stop ₹770, as stated.
No time frame is stated, so it is tracked until a close reaches ₹840 or ₹770: there is no fixed window.
The stop ₹770 was reached on a close before the target ₹840. Miss.
The grader’s working: R3 TRADE_SETUP: entered ₹798.4 on 2025-04-01 (stated entry ₹790–800 zone, ZONE entry, filled); stop ₹770 breached at close ₹759.6 on 2025-04-07. No time frame is stated and the call gives both a target and a stop, so it is tracked until a close reaches one of them (rule H6): the target first is a hit, the stop first a miss, and until then it stays open.